Mark C. POZNANSKY

Person

Newton, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Localized delivery of anti-fugetactic agent for treatment of cancer
- Patent number 11,890,348
- Issue date Feb 6, 2024
- The General Hospital Corporation
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antigen-binding fusion proteins with modified HSP70 domains
- Patent number 11,718,683
- Issue date Aug 8, 2023
- Aperisys, Inc.
- Timothy Brauns
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Coxiella burnetii epitopes for T cell-targeted Q fever vaccines
- Patent number 11,690,902
- Issue date Jul 4, 2023
- The General Hospital Corporation
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CXCR4/CXCR7 blockade and treatment of human papilloma virus-associa...
- Patent number 11,547,694
- Issue date Jan 10, 2023
- The General Hospital Corporation
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
HSP fusion protein with anti-chemorepellant agent for treatment of...
- Patent number 11,453,706
- Issue date Sep 27, 2022
- The General Hospital Corporation
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified natural killer cells for the treatment of cancer
- Patent number 11,419,894
- Issue date Aug 23, 2022
- The General Hospital Corporation
- Mark C. Poznansky
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Ex vivo antigen-presenting cells or activated CD-positive T cells f...
- Patent number 11,364,264
- Issue date Jun 21, 2022
- The General Hospital Corporation
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
HSP fusion protein with anti-chemorepellant agent for treatment of...
- Patent number 11,325,951
- Issue date May 10, 2022
- The General Hospital Corporation
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-fugetactic agent and anti-cancer agent combination therapy and...
- Patent number 11,305,017
- Issue date Apr 19, 2022
- The General Hospital Corporation
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating cervical neoplasia in patients infected with hum...
- Patent number 11,029,313
- Issue date Jun 8, 2021
- The General Hospital Corporation
- Mark C. Poznansky
- G01 - MEASURING TESTING
Information Patent Grant
Immunotherapies employing self-assembling vaccines
- Patent number 10,800,837
- Issue date Oct 13, 2020
- The General Hospital Corporation
- Jeffrey A. Gelfand
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Eluting matrix and uses thereof
- Patent number 10,580,262
- Issue date Mar 3, 2020
- The General Hospital Corporation
- Mark C. Poznansky
- C09 - DYES PAINTS POLISHES NATURAL RESINS ADHESIVES MISCELLANEOUS COMPOSITION...
Information Patent Grant
Antifugetactic agents for the treatment of cancers
- Patent number 10,406,217
- Issue date Sep 10, 2019
- The General Hospital Corporation
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for detecting and treating cancer
- Patent number 9,885,720
- Issue date Feb 6, 2018
- The General Hospital Corporation
- Mark C. Poznansky
- G01 - MEASURING TESTING
Information Patent Grant
Eluting matrix and uses thereof
- Patent number 9,849,159
- Issue date Dec 26, 2017
- The General Hospital Corporation
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Eluting matrix and uses thereof
- Patent number 9,849,094
- Issue date Dec 26, 2017
- The General Hospital Corporation
- Mark Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-fugetactic agents for the treatment of ovarian cancer
- Patent number 9,789,171
- Issue date Oct 17, 2017
- The General Hospital Corporation
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Eluting matrix and uses thereof
- Patent number 9,775,816
- Issue date Oct 3, 2017
- The General Hospital Corporation
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunotherapies employing self-assembling vaccines
- Patent number 9,527,906
- Issue date Dec 27, 2016
- The General Hospital Corporation
- Jeffrey A. Gelfand
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for detecting and treating cancer
- Patent number 9,229,004
- Issue date Jan 5, 2016
- The General Hospital Corporation
- Mark C. Poznansky
- G01 - MEASURING TESTING
Information Patent Grant
Cell therapy for limiting overzealous inflammatory reactions in tis...
- Patent number 9,220,813
- Issue date Dec 29, 2015
- Holy Cross Hospital, Inc.
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recovery of tissue function following administration of B cells to...
- Patent number 8,603,463
- Issue date Dec 10, 2013
- Holy Cross Hospital, Inc.
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CaR receptor as a mediator of migratory cell chemotaxis and/or chem...
- Patent number 7,951,364
- Issue date May 31, 2011
- The General Hospital Corporation
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Purposeful movement of human migratory cells away from an agent source
- Patent number 7,775,469
- Issue date Aug 17, 2010
- The General Hospital Corporation
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fugetactic proteins, compositions and methods of use
- Patent number 7,745,578
- Issue date Jun 29, 2010
- The General Hospital Corporation
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recovery of tissue function following administration of B cells to...
- Patent number 7,695,712
- Issue date Apr 13, 2010
- ACTX, Inc.
- Mark C. Poznansky
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Lymphoid tissue-specific cell production from hematopoietic progeni...
- Patent number 7,192,769
- Issue date Mar 20, 2007
- Cytomatrix, LLC
- Mark J. Pykett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
CaR receptor as a mediator of migratory cell chemotaxis and/or chem...
- Patent number 7,176,243
- Issue date Feb 13, 2007
- The General Hospital Corporation
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Purposeful movement of human migratory cells away from an agent source
- Patent number 7,141,363
- Issue date Nov 28, 2006
- The General Hospital Corporation
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Lymphoid tissue-specific cell production from hematopoietic progeni...
- Patent number 6,548,299
- Issue date Apr 15, 2003
- Mark J. Pykett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
LOCALIZED DELIVERY OF ANTI-FUGETACTIC AGENT FOR TREATMENT OF CANCER
- Publication number 20240293564
- Publication date Sep 5, 2024
- The General Hospital Corporation
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR IDENTIFYING CROSS-MODAL FEATURES FROM SPATIALLY RESOLVE...
- Publication number 20230306761
- Publication date Sep 28, 2023
- The General Hospital Corporation
- Ruxandra F. SIRBULESCU
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Application
IMMUNOTHERAPIES EMPLOYING SELF-ASSEMBLING VACCINES
- Publication number 20230192828
- Publication date Jun 22, 2023
- The General Hospital Corporation
- Jeffrey A. Gelfand
- C07 - ORGANIC CHEMISTRY
Information Patent Application
B CELL IMMUNOMODULATORY THERAPY FOR ACUTE RESPIRATORY DISTRESS SYND...
- Publication number 20230158074
- Publication date May 25, 2023
- The General Hospital Corporation
- Mark C. POZNANSKY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CXCR4/CXCR7 Blockade and Treatment of Human Papilloma Virus-Associa...
- Publication number 20230149347
- Publication date May 18, 2023
- The General Hospital Corporation
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EX VIVO ANTIGEN-PRESENTING CELLS OR ACTIVATED CD-POSITIVE T CELLS F...
- Publication number 20220323493
- Publication date Oct 13, 2022
- The General Hospital Corporation
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELF-ASSEMBLED VACCINES AND COMBINATION THERAPIES FOR TREATING CANCER
- Publication number 20220273780
- Publication date Sep 1, 2022
- The General Hospital Corporation
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HSP Fusion Protein with Anti-Chemorepellant Agent for Treatment of...
- Publication number 20220275032
- Publication date Sep 1, 2022
- The General Hospital Corporation
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-FUGETACTIC AGENT AND ANTI-CANCER AGENT COMBINATION THERAPY AND...
- Publication number 20220226474
- Publication date Jul 21, 2022
- The General Hospital Corporation
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
B CELL IMMUNOTHERAPY
- Publication number 20220079986
- Publication date Mar 17, 2022
- The General Hospital Corporation
- Mark C. POZNANSKY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOTHERAPIES EMPLOYING SELF-ASSEMBLING VACCINES
- Publication number 20210179697
- Publication date Jun 17, 2021
- The General Hospital Corporation
- Jeffrey A. Gelfand
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COXIELLA BURNETII EPITOPES FOR T CELL-TARGETED Q FEVER VACCINES
- Publication number 20210113679
- Publication date Apr 22, 2021
- The General Hospital Corporation
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF CXCL12 TO PROMOTE SURVIVAL, FUNCTION, AND IMMUNOISOLATION OF...
- Publication number 20200323784
- Publication date Oct 15, 2020
- The General Hospital Corporation
- Mark Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EX VIVO ANTIGEN-PRESENTING CELLS OR ACTIVATED CD-POSITIVE T CELLS F...
- Publication number 20200215110
- Publication date Jul 9, 2020
- The General Hospital Corporation
- Mark C. Poznansky
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Reprogramming of CD8 T Cells with CXCL12 Signaling Inhibitors
- Publication number 20200190202
- Publication date Jun 18, 2020
- The General Hospital Corporation
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIFUGETACTIC AGENTS FOR THE TREATMENT OF CANCERS
- Publication number 20200155659
- Publication date May 21, 2020
- The General Hospital Corporation
- Mark C. Poznansky
- G01 - MEASURING TESTING
Information Patent Application
Antigen-Binding Fusion Proteins with Modified HSP70 Domains
- Publication number 20200095332
- Publication date Mar 26, 2020
- The General Hospital Corporation
- Timothy Brauns
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-FUGETACTIC AGENT AND ANTI-CANCER AGENT COMBINATION THERAPY AND...
- Publication number 20200093928
- Publication date Mar 26, 2020
- The General Hospital Corporation
- Mark C. Poznansky
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cancer Treatment with a CXCL12 Signaling Inhibitor and an Immune Ch...
- Publication number 20200093789
- Publication date Mar 26, 2020
- The General Hospital Corporation
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CXCR4/CXCR7 Blockade and Treatment of Human Papilloma Virus-Associa...
- Publication number 20200030286
- Publication date Jan 30, 2020
- The General Hospital Corporation
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HSP FUSION PROTEIN WITH ANTI-CHEMOREPELLANT AGENT FOR TREATMENT OF...
- Publication number 20190375800
- Publication date Dec 12, 2019
- The General Hospital Corporation
- Mark C. Poznansky
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HSP FUSION PROTEIN WITH ANTI-CHEMOREPELLANT AGENT FOR TREATMENT OF...
- Publication number 20190375801
- Publication date Dec 12, 2019
- The General Hospital Corporation
- Mark C. Poznansky
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EX VIVO ANTIGEN-PRESENTING CELLS OR ACTIVATED CD-POSITIVE T CELLS F...
- Publication number 20190374575
- Publication date Dec 12, 2019
- The General Hospital Corporation
- Mark C. Poznansky
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODIFIED NATURAL KILLER CELLS FOR THE TREATMENT OF CANCER
- Publication number 20190269729
- Publication date Sep 5, 2019
- The General Hospital Corporation
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF TUMORS WITH INHIBITORS OF CXCL12 SIGNALING AND SUBTHER...
- Publication number 20190133998
- Publication date May 9, 2019
- The General Hospital Corporation
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOTHERAPIES EMPLOYING SELF-ASSEMBLING VACCINES
- Publication number 20190135902
- Publication date May 9, 2019
- THE GENERAL HOSPITAL CORPORATION
- Jeffrey A. Gelfand
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
UNIT DOSE FORMULATIONS FOR USE AS AN ANTI-FUGETACTIC AGENT
- Publication number 20180353472
- Publication date Dec 13, 2018
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED IMMUNE CELLS AND USES THEREOF
- Publication number 20180325953
- Publication date Nov 15, 2018
- APERISYS, INC.
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED T-CELLS HAVING ANTI-FUGETACTIC PROPERTIES AND USES THEREOF
- Publication number 20180273897
- Publication date Sep 27, 2018
- The General Hospital Corporation
- Mark C. Poznansky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LOCALIZED DELIVERY OF ANTI-FUGETACTIC AGENT FOR TREATMENT OF CANCER
- Publication number 20180256742
- Publication date Sep 13, 2018
- Mark C. Poznansky
- C07 - ORGANIC CHEMISTRY

Mark C. POZNANSKY

Person

Patents Grantslast 30 patents

Localized delivery of anti-fugetactic agent for treatment of cancer

Antigen-binding fusion proteins with modified HSP70 domains

Coxiella burnetii epitopes for T cell-targeted Q fever vaccines

CXCR4/CXCR7 blockade and treatment of human papilloma virus-associa...

HSP fusion protein with anti-chemorepellant agent for treatment of...

Modified natural killer cells for the treatment of cancer

Ex vivo antigen-presenting cells or activated CD-positive T cells f...

HSP fusion protein with anti-chemorepellant agent for treatment of...

Anti-fugetactic agent and anti-cancer agent combination therapy and...

Method of treating cervical neoplasia in patients infected with hum...

Immunotherapies employing self-assembling vaccines

Eluting matrix and uses thereof

Antifugetactic agents for the treatment of cancers

Methods for detecting and treating cancer

Eluting matrix and uses thereof

Eluting matrix and uses thereof

Anti-fugetactic agents for the treatment of ovarian cancer

Eluting matrix and uses thereof

Immunotherapies employing self-assembling vaccines

Methods for detecting and treating cancer

Cell therapy for limiting overzealous inflammatory reactions in tis...

Recovery of tissue function following administration of B cells to...

CaR receptor as a mediator of migratory cell chemotaxis and/or chem...

Purposeful movement of human migratory cells away from an agent source

Fugetactic proteins, compositions and methods of use

Recovery of tissue function following administration of B cells to...

Lymphoid tissue-specific cell production from hematopoietic progeni...

CaR receptor as a mediator of migratory cell chemotaxis and/or chem...

Purposeful movement of human migratory cells away from an agent source

Lymphoid tissue-specific cell production from hematopoietic progeni...

Patents Applicationslast 30 patents

LOCALIZED DELIVERY OF ANTI-FUGETACTIC AGENT FOR TREATMENT OF CANCER

METHODS FOR IDENTIFYING CROSS-MODAL FEATURES FROM SPATIALLY RESOLVE...

IMMUNOTHERAPIES EMPLOYING SELF-ASSEMBLING VACCINES

B CELL IMMUNOMODULATORY THERAPY FOR ACUTE RESPIRATORY DISTRESS SYND...

CXCR4/CXCR7 Blockade and Treatment of Human Papilloma Virus-Associa...

EX VIVO ANTIGEN-PRESENTING CELLS OR ACTIVATED CD-POSITIVE T CELLS F...

SELF-ASSEMBLED VACCINES AND COMBINATION THERAPIES FOR TREATING CANCER

HSP Fusion Protein with Anti-Chemorepellant Agent for Treatment of...

ANTI-FUGETACTIC AGENT AND ANTI-CANCER AGENT COMBINATION THERAPY AND...

B CELL IMMUNOTHERAPY

IMMUNOTHERAPIES EMPLOYING SELF-ASSEMBLING VACCINES

COXIELLA BURNETII EPITOPES FOR T CELL-TARGETED Q FEVER VACCINES

USE OF CXCL12 TO PROMOTE SURVIVAL, FUNCTION, AND IMMUNOISOLATION OF...

EX VIVO ANTIGEN-PRESENTING CELLS OR ACTIVATED CD-POSITIVE T CELLS F...

Reprogramming of CD8 T Cells with CXCL12 Signaling Inhibitors

ANTIFUGETACTIC AGENTS FOR THE TREATMENT OF CANCERS

Antigen-Binding Fusion Proteins with Modified HSP70 Domains

ANTI-FUGETACTIC AGENT AND ANTI-CANCER AGENT COMBINATION THERAPY AND...

Cancer Treatment with a CXCL12 Signaling Inhibitor and an Immune Ch...

CXCR4/CXCR7 Blockade and Treatment of Human Papilloma Virus-Associa...

HSP FUSION PROTEIN WITH ANTI-CHEMOREPELLANT AGENT FOR TREATMENT OF...

HSP FUSION PROTEIN WITH ANTI-CHEMOREPELLANT AGENT FOR TREATMENT OF...

EX VIVO ANTIGEN-PRESENTING CELLS OR ACTIVATED CD-POSITIVE T CELLS F...

MODIFIED NATURAL KILLER CELLS FOR THE TREATMENT OF CANCER

TREATMENT OF TUMORS WITH INHIBITORS OF CXCL12 SIGNALING AND SUBTHER...

IMMUNOTHERAPIES EMPLOYING SELF-ASSEMBLING VACCINES

UNIT DOSE FORMULATIONS FOR USE AS AN ANTI-FUGETACTIC AGENT

MODIFIED IMMUNE CELLS AND USES THEREOF

MODIFIED T-CELLS HAVING ANTI-FUGETACTIC PROPERTIES AND USES THEREOF

LOCALIZED DELIVERY OF ANTI-FUGETACTIC AGENT FOR TREATMENT OF CANCER